Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zalep-lon) and crystalline forms of zaleplon accessible with the process

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7348429
APP PUB NO 20050065168A1
SERIAL NO

10952151

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are novel Zaleplon crystalline Forms II, III, IV and V, which are useful for the treatment of insomnia. Also provided are processes for making Forms I, II, and V using precipitation methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAGPALAGI UT NO 13 DEBRECEN 4042

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Feher, Erika Debrecen, HU 8 7
Korodi, Ferenc Debrecen, HU 16 31
Magyar, Erika Debrecen, HU 6 7
Singer, Claude Kafar Saba, IL 76 201

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation